Ausgabe 1/1997
Inhalt (10 Artikel)
Midkine expression in human breast cancers: Expression of truncated form
Isao Miyashiro, Tadashi Kaname, Eisei Shin, Eijiro Wakasugi, Takushi Monden, Yuichi Takatsuka, Nobuteru Kikkawa, Takashi Muramatsu, Morito Monden, Tetsu Akiyama
Cell proliferation as a predictor of response to chemotherapy in metastatic breast cancer: A prospective study
Dino Amadori, Annalisa Volpi, Roberta Maltoni, Oriana Nanni, Laura Amaducci, Andrea Amadori, Donata Casadei Giunchi, Antonio Vio, Ariele Saragoni, Rosella Silvestrini
Comparison of action of the anti-neoplastic drug lonidamine on drug-sensitive and drug-resistant human breast cancer cells:31 P and 13C nuclear magnetic resonance studies
Antonio Vivi, Maria Tassini, Hava Ben-Horin, Gil Navon, Ofer Kaplan
A retrospective comparison of detection and treatment of breast cancer in young and elderly patients
L. Repetto, M. Costantini, E. Campora, D. Amoroso, W. Gianni, A. Catturich, C. Vecchio, C. Simoni, V. Marigliano, R. Rosso, L. Santi
The rise of tamoxifen: Temporal and geographical trends of tamoxifen use in Ontario
Valerie A. Palda, Vivek Goel, Carol A. Sawka
Proliferating cell nuclear antigen and heat shock protein 70 immuno-localization in invasive ductal breast cancer not otherwise specified
Andreas Ch. Lazaris, Emmy B. Chatzigianni, Dimitris Panoussopoulos, George N. Tzimas, Panayotis S. Davaris, Basil Ch. Golematis
Mitogenic activity toward human breast cancer cell line MCF-7 of two bFGFs purified from sera of breast cancer patients: co-operative role of cathepsin D
Yoshifumi Takei, Hanae Higashira, Toshiya Yamamoto, Kyozo Hayashi
Association of body mass index, physical activity, and reproductive histories with breast cancer: a case-control study in Gifu, Japan
Yao-Hua Hu, Chisato Nagata, Hiroyuki Shimizu, Nobuyuki Kaneda, Yoshitomo Kashiki
Breast conserving surgery for invasive breast cancer: Risk factors for ipsilateral breast tumor recurrences
K. Dalberg, A. Mattsson, L.E. Rutqvist, U. Johansson, L. Riddez, K. Sandelin
Influence of circulating c-erbB-2 serum protein on response to adjuvant chemotherapy in node-positive breast cancer patients
Tanja Fehm, Peter Maimonis, Stephen Weitz, Yosh Teramoto, Alexander Katalinic, Wolfram Jäger